The Cutting Edge of Medical Technology Content, Community & Collaboration
University of Utah Launches 23 New Startups in Fiscal year 2009 ... Cementing Reputation as Spinout Leader
Colleagues,
As reported in Genome Web News ... The University of Utah said last week that it spun out 23 companies in fiscal year 2009, including 10 in the biomedical arena, and has launched 82 companies over the past four years — more than any other US school during that period except the Massachusetts Institute of Technology and the University of California system.
... "The fact that the university is performing so well in a down economy illustrates the strength of the model being developed at the University of Utah," MedTech-IQ Member, Brian Cummings, assistant vice president in charge of the Technology Commercialization Office, said in a statement ... The university credits its spinout success to a reorganization of its tech-transfer functions four years ago along with a concerted effort by university administrators to change the philosophy behind technology commercialization at the school ...
New University of Utah spinouts for FY 2009 include:
• BlackRock, which provides tools for neuroscience, neural engineering, and neuroprosthetics research and clinical use.
• Branching Tree, which develops drug-delivery products using injectable thermogels.
• Integratech, which is attempting to commercialize a new screening system to develop new HIV drugs.
• JSK Therapeutics, which is developing novel anti-cancer drugs using an approved compound to inhibit the growth of cancer cells.
• Marrek, which is developing novel algorithms for post-ablation monitoring and tracking of lesions.
• Nanomedic, developing technology for diagnosing and treating age-related diseases such as Alzheimer's, osteoporosis, and cancer.
• RNA Biosciences, developing diagnostic and personalized health clinical tests to improve the care of patients with liver disease.
• Sera Prognostics, created to commercialize a joint invention with Brigham Young University to establish a diagnostic platform for preeclampsia and pre-term birth.
• TheraRenal, developing anti-obesity compounds using novel nitrated fatty acids.
• TheraTarget, which was created to commercialize polymer-delivery technologies coupled with cancer therapeutics.
The other 13 spinouts include companies in the cleantech, energy, engineering, agriculture, and consumer products spaces....
Read on at: http://www.genomeweb.com/biotechtransferweek/university-utah-launch...
ENJOY!
CC
As reported in Genome Web News ... The University of Utah said last week that it spun out 23 companies in fiscal year 2009, including 10 in the biomedical arena, and has launched 82 companies over the past four years — more than any other US school during that period except the Massachusetts Institute of Technology and the University of California system.
... "The fact that the university is performing so well in a down economy illustrates the strength of the model being developed at the University of Utah," MedTech-IQ Member, Brian Cummings, assistant vice president in charge of the Technology Commercialization Office, said in a statement ... The university credits its spinout success to a reorganization of its tech-transfer functions four years ago along with a concerted effort by university administrators to change the philosophy behind technology commercialization at the school ...
New University of Utah spinouts for FY 2009 include:
• BlackRock, which provides tools for neuroscience, neural engineering, and neuroprosthetics research and clinical use.
• Branching Tree, which develops drug-delivery products using injectable thermogels.
• Integratech, which is attempting to commercialize a new screening system to develop new HIV drugs.
• JSK Therapeutics, which is developing novel anti-cancer drugs using an approved compound to inhibit the growth of cancer cells.
• Marrek, which is developing novel algorithms for post-ablation monitoring and tracking of lesions.
• Nanomedic, developing technology for diagnosing and treating age-related diseases such as Alzheimer's, osteoporosis, and cancer.
• RNA Biosciences, developing diagnostic and personalized health clinical tests to improve the care of patients with liver disease.
• Sera Prognostics, created to commercialize a joint invention with Brigham Young University to establish a diagnostic platform for preeclampsia and pre-term birth.
• TheraRenal, developing anti-obesity compounds using novel nitrated fatty acids.
• TheraTarget, which was created to commercialize polymer-delivery technologies coupled with cancer therapeutics.
The other 13 spinouts include companies in the cleantech, energy, engineering, agriculture, and consumer products spaces....
Read on at: http://www.genomeweb.com/biotechtransferweek/university-utah-launch...
ENJOY!
CC
Views: 0
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
